Earth Science Tech, Inc. (ETST) Issues Directive Industry Classification Update to SIC 2834; Formally Identifies as Pharmaceutical Entity Since 2022

Core Viewpoint - Earth Science Tech, Inc. (ETST) is formally directing financial data providers to update their databases to reflect its transition to a pharmaceutical company, moving away from its previous association with CBD and cannabis [1][2][3]. Company Transition - Since 2022, ETST has shifted its focus from legacy industries to the healthcare and pharmaceutical sectors, emphasizing the need for accurate industry classification [2][3]. - The company has received SEC clearance for its classification as a pharmaceutical entity under SIC 2834, which has been in effect since 2022 [3]. Regulatory Compliance - ETST is actively engaging with major financial data platforms like Bloomberg, Morningstar, and S&P Global to ensure that its new classification is reflected across all financial websites [4]. - The recent clearance of the 15c-211 regulatory step is highlighted as a significant milestone in establishing ETST as a transparent and compliant pharmaceutical entity [3]. Operational Overview - ETST operates through various subsidiaries, including RxCompoundStore.com, Peaks Curative, and Mister Meds, focusing on compounding pharmaceuticals, telemedicine, and real estate development [5][8]. - The company is pursuing licensure for its pharmacies in all U.S. states and has expanded its services to include veterinary medicine through the acquisition of Zoolzy.com [9]. Business Model - ETST's business model includes the manufacturing of specialized medications and the management of telemedicine services, ensuring a comprehensive approach to healthcare delivery [8][9]. - The company is also involved in real estate through Avenvi, which manages a $10 million share repurchase program and oversees various investment activities [11].